Preventive cardiology| Volume 105, ISSUE 5, P664-666, March 01, 2010

Download started.


Lipid-Lowering Efficacy of Red Yeast Rice in a Population Intolerant to Statins

      Chinese red yeast rice is a dietary supplement containing monacolins, unsaturated fatty acids, and phytosterols capable of lowering low-density lipoprotein (LDL) cholesterol. Few studies have reported on its use in clinical practice or in statin-intolerant patients. We reviewed approximately 1,400 clinical charts and identified 25 patients treated with red yeast rice for ≥4 weeks. The patients were included if they had pre- and post-treatment lipid levels without simultaneous changes in other lipid-lowering medications. These patients had experienced myalgias (68%), gastrointestinal intolerance (16%), and/or elevated alanine aminotransferase levels (8%) with previous use of other lipid-lowering agents. The total cholesterol decreased 15% (−37 ± 26 mg/dl, p <0.001) and LDL cholesterol decreased 21% (−35 ± 25 mg/dl, p <0.001) during 74 ± 39 days of treatment. Most (92%) patients tolerated the treatment, and many (56%) achieved their LDL cholesterol goal. In patients unable to tolerate daily statin use, the total cholesterol level decreased 13% (−33 ± 10 mg/dl, p <0.001) and LDL cholesterol decreased 19% (−31 ± 4 mg/dl, p <0.001). In conclusion, red yeast rice modestly decreased total and LDL cholesterol, was well-tolerated, and was an acceptable alternative in patients intolerant of other lipid-lowering medications.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bruckert E.
        • Hayem G.
        • Dejager S.
        • Yau C.
        • Begaud B.
        Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients—the PRIMO study.
        Cardiovasc Drugs Ther. 2005; 19: 403-414
        • Heber D.
        • Lembertas A.
        • Lu Q.Y.
        • Bowerman S.
        • Go V.L.
        An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents.
        J Altern Complement Med. 2001; 7: 133-139
        • Ma J.
        • Li Y.
        • Ye Q.
        • Li J.
        • Hua Y.
        • Ju D.
        • Zhang D.
        • Cooper R.
        • Chang M.
        Constituents of red yeast rice, a traditional Chinese food and medicine.
        J Agric Food Chem. 2000; 48: 5220-5225
        • Goldstein M.R.
        Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis.
        Am J Med. 2000; 109: 72-73
        • Expert Panel on DetectionEvaluationTreatment of High Blood Cholesterol in Adults
        Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Heber D.
        • Yip I.
        • Ashley J.M.
        • Elashoff D.A.
        • Elashoff R.M.
        • Go V.L.
        Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement.
        Am J Clin Nutr. 1999; 69: 231-236
        • Lin C.C.
        • Li T.C.
        • Lai M.M.
        Efficacy and safety of Monascus purpureus went rice in subjects with hyperlipidemia.
        Eur J Endocrinol. 2005; 153: 679-686
        • Liu J.
        • Zhang J.
        • Shi Y.
        • Grimsgaard S.
        • Alraek T.
        • Fonnebo V.
        Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials.
        Chin Med. 2006; 1: 4
        • Becker D.J.
        • Gordon R.Y.
        • Morris P.B.
        • Yorko J.
        • Gordon Y.J.
        • Li M.
        • Iqbal N.
        Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial.
        Mayo Clin Proc. 2008; 83: 758-764
        • Becker D.J.
        • Gordon R.Y.
        • Halbert S.C.
        • French B.
        • Morris P.B.
        • Rader D.J.
        Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.
        Ann Intern Med. 2009; 150: 830-839
        • Huang C.F.
        • Li T.C.
        • Lin C.C.
        • Liu C.S.
        • Shih H.C.
        • Lai M.M.
        Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients.
        Eur J Cardiovasc Prev Rehabil. 2007; 14: 438-440
        • Cartin-Ceba R.
        • Lu L.B.
        • Kolpakchi A.
        A “natural” threat.
        Am J Med. 2007; 120: e3-e4
        • Mueller P.S.
        Symptomatic myopathy due to red yeast rice.
        Ann Intern Med. 2006; 145: 474-475
        • Smith D.J.
        • Olive K.E.
        Chinese red rice-induced myopathy.
        South Med J. 2003; 96: 1265-1267
        • Vercelli L.
        • Mongini T.
        • Olivero N.
        • Rodolico C.
        • Musumeci O.
        • Palmucci L.
        Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment.
        J Am Geriatr Soc. 2006; 54: 718-720
        • Prasad G.V.
        • Wong T.
        • Meliton G.
        • Bhaloo S.
        Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient.
        Transplantation. 2002; 74: 1200-1201
        • Lapi F.
        • Gallo E.
        • Bernasconi S.
        • Vietri M.
        • Menniti-Ippolito F.
        • Raschetti R.
        • Gori L.
        • Firenzuoli F.
        • Mugelli A.
        • Vannacci A.
        Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian surveillance system of natural health products.
        Br J Clin Pharmacol. 2008; 66: 572-574
        • Roselle H.
        • Ekatan A.
        • Tzeng J.
        • Sapienza M.
        • Kocher J.
        Symptomatic hepatitis associated with the use of herbal red yeast rice.
        Ann Intern Med. 2008; 149: 516-517

      Linked Article

      • All Red Yeast Rice Products Are Not Created Equal—or Legal
        American Journal of CardiologyVol. 106Issue 3
        • Preview
          The American Journal of Cardiology recently published a reported titled “Lipid-Lowering Efficacy of Red Yeast Rice in a Population Intolerant to Statins.”1 The investigators reported that 25 patients with known histories of intolerance to statin drugs, when treated with red yeast rice, averaged a 21% decrease in low-density lipoprotein cholesterol, with few side effects. In this uncontrolled study, patients were allowed to purchase their own choices of red yeast rice products, and their selections were not reported.
        • Full-Text
        • PDF